Palliation of pancreatic neoplasms.

Minerva Chir

Department of Clinical and Surgical Sciences (Surgery), Royal Infirmary of Edinburgh, Edinburgh, UK.

Published: April 2004

Pancreatic adenocarcinoma accounts for 80% of pancreatic tumours. The majority are unresectable at diagnosis and only 10% of patients survive to 1 year. Therefore, selection of appropriate palliative procedures for jaundice, gastric outlet obstruction or pain is a vitally important aspect of the management of these patients. Overall survival is equivalent following surgical or non-surgical palliation of biliary obstruction. Operative biliary bypass is a more major intervention but is associated with longer relief of symptoms and fewer readmissions compared to non-operative procedures. Prognostic factors such as histopathology, presence of metastatic disease and C reactive protein levels may allow better prediction of survival, therefore aiding selection of the most appropriate palliative techniques.

Download full-text PDF

Source

Publication Analysis

Top Keywords

selection appropriate
8
appropriate palliative
8
palliation pancreatic
4
pancreatic neoplasms
4
neoplasms pancreatic
4
pancreatic adenocarcinoma
4
adenocarcinoma accounts
4
accounts 80%
4
80% pancreatic
4
pancreatic tumours
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!